These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20684683)

  • 1. The urgent need for recommendations on revaccination of HIV-infected children after successful antiretroviral therapy.
    Rainwater-Lovett K; Moss WJ
    Clin Infect Dis; 2010 Sep; 51(5):634-5. PubMed ID: 20684683
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2010 May; 50(10):1415-8. PubMed ID: 20377409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children.
    Berkelhamer S; Borock E; Elsen C; Englund J; Johnson D
    Clin Infect Dis; 2001 Apr; 32(7):1090-4. PubMed ID: 11264038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.
    Belaunzarán-Zamudio PF; García-León ML; Wong-Chew RM; Villasís-Keever A; Cuellar-Rodríguez J; Mosqueda-Gómez JL; Muñoz-Trejo T; Escobedo K; Santos JI; Ruiz-Palacios GM; Sierra-Madero JG
    Vaccine; 2009 Nov; 27(50):7059-64. PubMed ID: 19799846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMR vaccine in HIV-infected children -- potential hazards?
    Goon P; Cohen B; Jin L; Watkins R; Tudor-Williams G
    Vaccine; 2001 Jul; 19(28-29):3816-9. PubMed ID: 11427252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles immunity in HIV-infected children.
    Walter EB; Katz SL; Bellini WJ
    Pediatr AIDS HIV Infect; 1994 Oct; 5(5):300-4. PubMed ID: 11361371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to measles, mumps, and rubella revaccination among HIV-positive and HIV-negative children and adolescents with hemophilia. Hemophilia Growth and Development Study.
    Hilgartner MW; Maeder MA; Mahoney EM; Donfield SM; Evatt BL; Hoots WK
    Am J Hematol; 2001 Feb; 66(2):92-8. PubMed ID: 11421305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization status of children born to human immunodeficiency virus (HIV)-infected mothers in two Texas cities.
    Schulte JM; Burkham S; Squires JE; Doran T; Hamaker DW; Pelosi J; Graper J; Davis R; Caldwell MB
    South Med J; 2000 Jan; 93(1):48-52. PubMed ID: 10653065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
    Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the use of antiretroviral agents in pediatric HIV infection--HRSA. Request for comments.
    Fed Regist; 1997 Sep; 62(189):51115-6. PubMed ID: 10175219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [German-Austrian guidelines on antiretroviral therapy for HIV infections].
    Med Monatsschr Pharm; 1998 Jul; 21(7):205-11. PubMed ID: 9691629
    [No Abstract]   [Full Text] [Related]  

  • 15. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.
    Puthanakit T; Bunupuradah T
    Curr Opin HIV AIDS; 2010 Jan; 5(1):12-7. PubMed ID: 20046143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles outbreak in an orphanage: HIV-infected children on antiretroviral therapy are still at risk.
    Aurpibul L; Puthanakit T; Kanjanavanit S; Sirisanthana T; Sirisanthana V
    Pediatr Infect Dis J; 2010 Feb; 29(2):167-9. PubMed ID: 19907357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric HIV: new opportunities to treat children.
    Van der Linden D; Callens S; Brichard B; Colebunders R
    Expert Opin Pharmacother; 2009 Aug; 10(11):1783-91. PubMed ID: 19558340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS.
    Pediatrics; 1999 May; 103(5 Pt 1):1057-60. PubMed ID: 10224192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(28):603-6. PubMed ID: 8676852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.